Vietnam's healthcare expenditures reached around $17 billion in 2019, photo Le Toan The second-largest pharmaceutical company in Japan, Daiichi Sankyo Co., Ltd., has entered a licence agreement with Mitsubishi Tanabe Pharma Corporation to register and launch edaravone brand Radicava in Vietnam. The medication treats patients with amyotrophic lateral sclerosis and helps with recovery from a stroke. Yukinori Tominaga, general director of Daiichi Sankyo Vietnam Co., Ltd., told VIR, "We are going to provide more access to new medications in order to increase options for Vietnamese doctors to improve the quality of life in Vietnamese people." The agreement is one of several plans by Daiichi Sankyo for Vietnam in 2021. It aims to contribute to the enrichment of quality of life in the country through the innovative pharmaceuticals from Daiichi Sankyo and external resources, as the Mitsubishi Tanabe case, in order to address diverse medical needs. Having established a representative office in Ho Chi Minh City in 2014 to provide support activities for the sale and promotion of its pharma products, last year Daiichi Sankyo strengthened its presence in Vietnam by announcing the establishment of its Vietnamese arm as a wholly-owned subsidiary to conduct sales activities. This is to better respond… Read full this story
- Four ways Rising Storm 2: Vietnam rises above the competition
- Report: Koei To Open Vietnam Studio, Cites Lower Dev Costs
- Seven Urbana campus faculty members named University Scholars
- Japan may send Chatty Humanoid Tweet-bot to Space
- Pokemon Sun and Moon Pokedex round-up: names, descriptions, leaks and more
- White Day: A Labyrinth Named School
- Takeda Submits Vedolizumab NDA for Treatment of Moderately to Severe UC in Japan
- Novartis Lung Disease Drug Approved in Japan
- Da Nang calls for hi-tech farms
- Microsoft’s Kinect continues to expand its role in modern medicine
Japan’s health names latch onto Vietnam have 284 words, post on www.vir.com.vn at February 5, 2021. This is cached page on VietMaz. If you want remove this page, please contact us.